Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio, and Alyftrek for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex has diversified its portfolio through Casgevy, a gene-editing therapy for beta thalassemia and sickle-cell disease, and Journavx, a non-opioid pain medication approved for the treatment of moderate-to-severe acute pain in adults. Additionally, Vertex is evaluating small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.
Quick Stats
May 22, 202664.8
AI Score
BUY1.49
Volume Ratio
May 04, 2026
Next Earnings
14
+ve Days (30d)
16
-ve Days (30d)
VRTX Stock Summary
Last updated May 22, 2026
VRTX is currently trading at $434.52, positioned below its 200-day moving average of $434.73, suggesting bearish momentum. The stock has a 52-week range of $362.5 to $507.92.
Technical Analysis: The 50-day moving average stands at $440.29, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 47.979, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.026, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates VRTX at 64.8/100 with a BUY recommendation.
VRTX (Vertex Pharmaceuticals Inc) Indicators
Last updated May 22, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 47.979 |
| CMF (20) | -0.026 |
| ROC (10) | 1.021 |
| ADX (14) | 19.295 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -1.265 |
| AROONOSC (14) | 50.0 |
| WILLAMS %R (14) | -50.597 |
| MFI (14) | 51.758 |
VRTX Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
VRTX Price vs Max Options Open Interest
VRTX Max Change In Options Open Interest
VRTX Options - Sort by Max open Interest (near term)
22nd May 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
VRTX Daily Out of Money Options - Sort by Max open Interest (near term)
22nd May 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
VRTX Daily In the Money Options - Sort by Max open Interest (near term)
22nd May 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
VRTX Most Active Options by Volume(near term)
22nd May 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Vertex Pharmaceuticals Inc is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
VRTX Moving Averages Analysis
VRTX (Vertex Pharmaceuticals Inc) Simple Moving Averages
Moving Averages are last updated May 22, 2026
| Days | MA |
|---|---|
| 10 | 439.33 |
| 20 | 433.03 |
| 30 | 434.75 |
| 50 | 440.29 |
| 100 | 454.72 |
| 200 | 434.73 |
VRTX Fundamental Analysis
| P/E (Forward) | 22.8311 |
| P/E (Trailing) | 25.5758 |
| Market Cap ($) | 109.2 billion |
| Earnings/Share ($) | 16.83 |
| Net Proft Margin (%) | 0.3551 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | 19.1405 |
| EPS Estimate Next Year ($) | 21.5032 |
| WallStreet Target Price ($) | 548.1035 |
| Most Recent Quarter |